According to Amedisys's latest financial reports the company's current EPS (TTM) is HK$0.78. In 2022 the company made an earnings per share (EPS) of HK$28.32 a decrease over its 2021 EPS that were of HK$49.66.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$0.76 | -97.31% |
2022 | HK$28.32 | -42.97% |
2021 | HK$49.66 | 13.68% |
2020 | HK$43.68 | 42.53% |
2019 | HK$30.65 | 8.22% |
2018 | HK$28.32 | 305.56% |
2017 | HK$6.98 | -19.64% |
2016 | HK$8.69 | -1118.18% |
2015 | -HK$0.85 | -128.21% |
2014 | HK$3.03 | -112.83% |
2013 | -HK$23.59 | 8.57% |
2012 | -HK$21.72 | -78.84% |
2011 | -HK$102.65 | -428.29% |
2010 | HK$31.27 | -19.08% |
2009 | HK$38.64 | 52.29% |
2008 | HK$25.37 | 29.76% |
2007 | HK$19.55 | 43.79% |
2006 | HK$13.60 | 20.86% |
2005 | HK$11.25 | 23.93% |
2004 | HK$9.08 | 81.4% |
2003 | HK$5.00 | -761.53% |
2002 | -HK$0.76 | -110.92% |
2001 | HK$6.92 | 46.91% |
2000 | HK$4.71 | |
1998 | -HK$50.01 | 1415.52% |
1997 | -HK$3.30 | -3212.38% |
1996 | HK$0.11 |